CGS Speaks

Science advocacy offers opportunities to influence policy, but how do you transition from the lab to the world of science policy?

We often get caught up in the details of our experiments, but how can we ensure our work connects with the larger mission?

From superbugs to microbiome balance, bacteriophages are shaping the future of bacterial control.

A growing number of studies suggest that pet ownership leads to better heart health and a reduced risk for cardiovascular disease.

Re-envisioning the path to STEM through MUSC neuroscience outreach.

Researchers are finding ways to address certain traumatic brain injuries that were once believed to be beyond recovery.

Mark Cuban's new approach to drug pricing offers hope for lower costs while highlighting the ongoing battle for fair and transparent medication pricing.

How an obscure drug became a household name, revolutionizing an industry in the process.

As an update to the recent FDA decision on MDMA-assisted therapy, new psychedelic treatments may require a different approach that reinforces ethical science.

The FDA will decide if the psychedelic drug MDMA will be the first newly approved treatment for PTSD in over two decades.